Skip to content
PDRN Care

PDRN vs Growth Factors: Which Is Better for Skin Regeneration?

Dr. Sarah Chen

PhD, Molecular Biology

March 30, 202611 min

Two Pillars of Regenerative Skincare

PDRN and growth factors are both used to promote skin regeneration, but they represent fundamentally different approaches. Growth factors are signaling proteins that tell cells what to do. PDRN is a DNA fragment that activates a specific receptor and provides cellular building blocks. Understanding this distinction is critical for choosing the right ingredient — or deciding to use both.

What Are Growth Factors?

Growth factors are naturally occurring proteins that regulate cell growth, proliferation, differentiation, and survival [4][7]. In skincare, the most commonly used growth factors include:

  • EGF (Epidermal Growth Factor) — Stimulates keratinocyte and fibroblast proliferation
  • FGF (Fibroblast Growth Factor) — Promotes fibroblast activity and angiogenesis
  • TGF-β (Transforming Growth Factor Beta) — Drives collagen synthesis and matrix remodeling
  • PDGF (Platelet-Derived Growth Factor) — Recruits cells to wound sites
  • VEGF (Vascular Endothelial Growth Factor) — Stimulates blood vessel formation

Growth factors in skincare products are typically produced via recombinant DNA technology (rh-EGF, rh-FGF) or derived from conditioned media of cultured stem cells [4][7].

How growth factors work

Growth factors bind to specific receptor tyrosine kinases on the cell surface, triggering intracellular signaling cascades (MAPK, PI3K/Akt, JAK/STAT pathways) that alter gene expression [7]. Each growth factor activates its own receptor and signaling pathway, producing specific cellular responses.

The challenge is that growth factors work through a "lock and key" model — they must reach their target receptor intact, in sufficient concentration, and with the correct three-dimensional protein structure to trigger signaling [4].

How PDRN Differs

PDRN (polydeoxyribonucleotide) is not a signaling protein. It is a purified DNA fragment (50-1500 kDa) from salmon sperm cells that works through two distinct mechanisms [1][8]:

  1. Adenosine A2A receptor activation — PDRN fragments bind to the adenosine A2A receptor on fibroblasts, endothelial cells, and immune cells, triggering cAMP-mediated signaling that promotes cell proliferation, collagen synthesis, angiogenesis, and anti-inflammatory responses [1][3].
  2. Nucleotide salvage pathway — PDRN fragments are broken down into individual nucleotides that cells incorporate through the nucleotide salvage pathway, providing raw materials for DNA synthesis and repair [1][8].

This dual mechanism means PDRN both signals cells to regenerate and provides the building blocks they need to do so.

Head-to-Head Comparison

Stability

This is one of the most significant practical differences between PDRN and growth factors.

Growth factors are large, complex proteins with specific three-dimensional structures that are essential for biological activity [7]. They are inherently fragile:

  • Heat, UV exposure, and pH changes can denature them
  • They have short half-lives outside the body (minutes to hours)
  • Formulation stability is challenging — many growth factor products lose potency on the shelf
  • Penetration through the skin barrier is limited by their large molecular size (6-25 kDa for most growth factors)

PDRN is a remarkably stable molecule [1][8]. As a DNA fragment rather than a protein:

  • It is resistant to heat and pH changes across a wide range
  • It maintains biological activity through standard product shelf life
  • Its smaller fragments can penetrate the skin barrier more effectively
  • Its mechanism does not depend on maintaining a specific three-dimensional structure

This stability advantage means PDRN in a topical serum is more likely to deliver its full biological activity than an equivalent growth factor product.

Evidence Base

PDRN has 20+ years of clinical use with multiple randomized controlled trials demonstrating efficacy in skin rejuvenation, wound healing, and tissue regeneration [1][2][6]. The evidence is consistent, reproducible, and spans injectable and topical delivery.

Growth factors have a more mixed evidence base [4][5]:

  • rh-EGF has the strongest clinical data among growth factors, particularly for wound healing [5]
  • Many growth factor skincare studies are sponsored by product manufacturers
  • Results are highly dependent on the specific growth factor, concentration, formulation, and delivery method
  • The theoretical concern about protein stability undermines confidence in topical product claims

Mechanism Specificity

PDRN works through a single, well-characterized receptor (A2A) plus the nucleotide salvage pathway [1]. This makes its effects predictable and reproducible.

Growth factors are diverse — each works through a different receptor and pathway [7]. A product containing EGF will have different effects than one containing FGF. Multi-growth-factor products attempt broader effects but introduce complexity and potential interactions that are difficult to study.

Safety

PDRN has an excellent safety record with no serious adverse events in clinical trials [1][2]. Its metabolites are natural nucleotides that enter normal cellular metabolism [8].

Growth factors raise theoretical concerns about stimulating abnormal cell growth, particularly in individuals with pre-existing conditions [7]. While no adverse events have been demonstrated in skincare applications, the broad mitogenic activity of some growth factors (particularly EGF) has prompted caution among some dermatologists.

Comparison Table

FactorPDRNGrowth Factors
MechanismA2A receptor + nucleotide supplyReceptor tyrosine kinase signaling
StabilityExcellent (DNA-based)Poor (protein-based)
Molecular Size50-1500 kDa (fragments)6-25 kDa (individual proteins)
Skin PenetrationGood (smaller fragments)Limited (protein size/charge)
Evidence LevelStrong (multiple RCTs)Mixed (varies by growth factor)
SpecificitySingle receptor, predictableMultiple receptors, complex
SourceSalmon DNA (standardized)Recombinant or conditioned media
CostModerateModerate to high

When to Choose PDRN

PDRN is the better choice when you want [1][2][3]:

  • A stable, evidence-based regenerative ingredient
  • Reliable activity in topical formulations
  • Combined regeneration and anti-inflammatory benefits
  • A well-understood safety profile
  • Targeted concerns like skin texture, hydration, post-procedure recovery, or general anti-aging

When Growth Factors May Complement PDRN

Growth factors can add value in specific scenarios [4][5]:

  • Professional injectable delivery (where stability is less of a concern)
  • Combination with PDRN for multi-pathway stimulation
  • Specific wound healing applications where rh-EGF has strong evidence
  • As part of PRP (platelet-rich plasma) therapy, which delivers growth factors in their natural carrier

Can You Use Both?

Yes, and many advanced skincare routines do. Since PDRN and growth factors work through entirely different mechanisms, they can be used together without interference [1][4]. A practical approach:

  • Use a PDRN serum as your daily regenerative base (reliable, stable)
  • Layer a growth factor product if desired (morning application when fresh from the bottle)
  • Consider professional PDRN treatments (injections, microneedling) for intensive regeneration
  • Reserve growth factor-heavy protocols (PRP, conditioned media) for clinical settings where delivery is controlled

The Bottom Line

PDRN and growth factors both promote skin regeneration, but PDRN offers significant practical advantages: superior stability, a more predictable mechanism, stronger clinical evidence in dermal rejuvenation, and excellent safety [1][2][3]. Growth factors have legitimate science behind them but face real-world challenges with stability and delivery that limit their reliability in topical products [4][7]. For most people building a regenerative skincare routine, PDRN is the more dependable foundation — and growth factors can be a complementary addition when sourced and delivered properly.

References

  1. [1]
    Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
  2. [2]
    Kim TH, Kim JY, Bae JH, et al.. Biostimulatory effects of polydeoxyribonucleotide for facial skin rejuvenation. J Cosmet Dermatol. 2019;18(6):1767-1773. doi:10.1111/jocd.12958
  3. [3]
    Colangelo MT, Galli C, Giannelli M. Polydeoxyribonucleotide: A Promising Biological Platform for Dermal Regeneration. Curr Pharm Des. 2020;26(17):2049-2056.
  4. [4]
    Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585-601. doi:10.1111/j.1524-475X.2008.00410.x
  5. [5]
    Esquirol-Caussa J, Herrero-Vila E. Human recombinant epidermal growth factor in skin lesions: 77 cases in EPItelizando project. J Dermatolog Treat. 2019;30(1):96-101. doi:10.1080/09546634.2018.1468028
  6. [6]
    Galeano M, Bitto A, Altavilla D, et al.. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen. 2008;16(2):208-217. doi:10.1111/j.1524-475X.2008.00361.x
  7. [7]
    Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835-870. doi:10.1152/physrev.2003.83.3.835
  8. [8]
    Veronesi F, Dallari D, Sabbioni G, Carubbi C, Martini L, Fini M. Polydeoxyribonucleotides (PDRNs): From Physical Chemistry to Biological Activities and Clinical Applications. Int J Mol Sci. 2017;18(9):1927. doi:10.3390/ijms18091927
ShareTwitterLinkedIn

Recommended Products

Related Posts

Search

Search across products, blog posts, wiki articles, and more.